- Home
- WNEB vs AMRN Comparison
WNEB vs AMRN Comparison
Compare WNEB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WNEB | AMRN |
|---|---|---|
| Founded | 1853 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | 80 |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.8M | 304.6M |
| IPO Year | 2001 | 1998 |
Fundamental Metrics
Financial Performance| Metric | WNEB | AMRN |
|---|---|---|
| Price | $13.21 | $14.67 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.50 | $12.00 |
| AVG Volume (30 Days) | ★ 54.0K | 50.1K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | 33.93 | ★ 55.00 |
| EPS | ★ 0.75 | N/A |
| Revenue | $44,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.61 | $1.26 |
| P/E Ratio | $17.59 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $7.74 | $7.94 |
| 52 Week High | $14.52 | $20.90 |
Technical Indicators
Market Signals| Indicator | WNEB | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 47.48 |
| Support Level | $12.07 | $13.65 |
| Resistance Level | $13.42 | $16.95 |
| Average True Range (ATR) | 0.29 | 0.55 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 96.40 | 49.70 |
Price Performance
Historical ComparisonAbout WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.